An enantioselective synthesis of (+)-(S)-[n]-gingerols via the l-proline-catalyzed aldol reaction

Bioorganic and Medicinal Chemistry Letters

Volumn 19, Issue 14, 2009, Pages 3909-3911

  Ma, Shichao ^a   Zhang, Shilei ^a   Duan, Wenhu ^a,b   Wang, Wei ^a,b,c  

^a EAST CHINA UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

^b SHANGHAI INSTITUTE OF MATERIA MEDICA   (China)

^c UNIVERSITY OF NEW MEXICO   (United States)

Author keywords

Cross aldol; Gingerols; Organocatalysis; Proline

Indexed keywords

GINGEROL; PROLINE;

ALDOL REACTION; ARTICLE; CATALYSIS; DRUG SYNTHESIS; ENANTIOSELECTIVITY;

ANTIOXIDANTS; CATALYSIS; CATECHOLS; FATTY ALCOHOLS; PROLINE; STEREOISOMERISM;

EID: 67649635546     PISSN: 0960894X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bmcl.2009.03.081     Document Type: Article

References (68)

1. List B., Lerner R.A., and Barbas III C.F. J. Am. Chem. Soc. 122 (2000) 2395
2. Recent reviews of chiral secondary amine catalyzed enamine chemistry, see:. List B. Acc. Chem. Res. 37 (2004) 548
3. Notz W., Tanaka F., and Barbas III C.F. Acc. Chem. Res. 37 (2004) 580
4. Mukherjee S., Yang J.W., Hoffmann S., and List B. Chem. Rev. 107 (2007) 5471
5. Selected examples of proline analogues catalyzed aldol reactions, see:. Sakthivel K., Notz W., Bui T., and Barbas III C.F. J. Am. Chem. Soc. 123 (2001) 5260
6. Saito S., Nakadai M., and Yamamoto H. Synlett (2001) 1245
7. Tang Z., Jiang F., Yu L.-T., Cui X., Gong L.-Z., Mi A.-Q., Jiang Y.-Z., and Wu Y.-D. J. Am. Chem. Soc. 125 (2003) 5262
8. Krattiger P., McCarthy C., Pfaltz A., and Wennemers H. Angew. Chem., Int. Ed. 42 (2003) 1722
9. Kofoed J., Nielsen J., and Reymond J.-L. Bioorg. Med. Chem. Lett. 13 (2003) 2445
10. Cobb A.J.A., Shaw D.M., and Ley S.V. Synlett (2004) 558
11. Torii H., Nakadai M., Ishihara K., Saito S., and Yamamoto H. Angew. Chem., Int. Ed. 43 (2004) 1983
12. Lacoste E., Landais Y., Schenk K., Verlhac J.-B., and Vincent J.-M. Tetrahedron Lett. 45 (2004) 8035
13. Berkessel A., Koch B., and Lex J. Adv. Synth. Catal. 346 (2004) 1141
14. Mangion I.K., Northrup A.B., and MacMillan D.W.C. Angew. Chem., Int. Ed. 43 (2004) 6722
15. Shi L.-X., Sun Q., Ge Z.-M., Zhu Y.-Q., Cheng T.-M., and Li R.-T. Synlett (2004) 2215
16. Cobb A.J.A., Shaw D.M., Longbottom D.A., and Ley S.V. Org. Biomol. Chem. 3 (2005) 84
17. Chimni S.S., Mahajan D., and Babu V.V.S. Tetrahedron Lett. 46 (2005) 5617
18. Bellis E., and Kokotos G. Tetrahedron 61 (2005) 8669
19. Chen J.-R., Lu H.-H., Li X.-Y., Cheng L., Wan J., and Xiao W.-J. Org. Lett. 7 (2005) 4543
20. Samanta S., Liu J., Dodda R., and Zhao C.-G. Org. Lett. 7 (2005) 5321
21. Gryko D., and Lipinski R. Adv. Synth. Catal. 347 (2005) 1948
22. Jiang M., Zhu S.-F., Yang Y., Gong L.-Z., Zhou X.-G., and Zhou Q.-L. Tetrahedron: Asymmetry 17 (2006) 384
23. Silva F., Sawicki M., and Gouverneur V. Org. Lett. 8 (2006) 5417
24. Guillena G., Hita M.C., and Njera C. Tetrahedron: Asymmetry 17 (2006) 729
25. Raj M., Vishnumaya, Ginotra S.K., and Singh V.K. Org. Lett. 8 (2006) 4097
26. Gryko D., Kowlaczyk B., and Zawadzki L. Synlett (2006) 1059
27. Cheng C., Sun J., Wang C., Zhang Y., Wei S., Jiang F., and Wu Y. Chem. Commun. (2006) 215
28. Gu L., Yu M., Wu X., Zhang Y., and Zhao G. Adv. Synth. Catal. 348 (2006) 2223
29. Mase N., Nakai Y., Ohara N., Yoda H., Takabe K., Tanaka F., and Barbas III C.F. J. Am. Chem. Soc. 128 (2006) 734
30. Hayashi Y., Sumiya T., Takahashi J., Gotoh H., Urushima T., and Shoji M. Angew. Chem., Int. Ed. 45 (2006) 958
31. Kano T., Yamaguchi Y., Tanaka Y., and Maruoka K. Angew. Chem., Int. Ed. 46 (2007) 1738
32. A review of application of organocatalysis in drug and total synthesis, see:. de Figueiredo R.M., and Christmann M. Eur. J. Org. Chem. (2007) 2575
33. We have explored the use of l-proline and its analogues catalzyed aldol reactions as key steps in the synthesis of biolgically interesting natural products and therapeutic agents:. Zhang S., Duan W., and Wang W. Adv. Synth. Catal. 348 (2006) 1228
34. Zhang S., Chen X., Zhang J., Wang W., and Duan W. Synthesis (2008) 383
35. Song L., Chen X., Zhang S.-L., Zhang H., Li P., Luo G., Liu W., Duan W.-H., and Wang W. Org. Lett. 10 (2008) 5489
36. Other selected examples of organocatalytic aldol reaction in drug and total synthesis, see:. Chandler C.L., and List B. J. Am. Chem. Soc. 130 (2008) 6737
37. Carpenter J., Northrup A.B., Chung D., Wiener J.J.M., Kim S.-G., and MacMillan D.W.C. Angew. Chem., Int. Ed. 47 (2008) 3568
38. Satoh N., Akiba T., Yokoshima S., and Fukuyama T. Angew. Chem., Int. Ed. 46 (2007) 5734
39. Pihko P.M., and Wekkilä A. Tetrahedron Lett. 44 (2003) 7607
40. Murad N.A., Ngah W.Z.W., Yusof Y.A.M., Abdul Aziz J.M., and Semarak J. Asian J. Biochem. 2 (2007) 421
41. Kim J.-K., Kim Y., Na K.-M., Surh Y.-J., and Kim T.-Y. Free Radical Res. 41 (2007) 603
42. Ahui M.L.B., Champy P., Ramadan A., Pham Van L., Araujo L., Brou Andre K., Diem S., Damotte D., Kati-Coulibaly S., Offoumou M.A., Dy M., Thieblemont N., and Herbelin A. Int. Immunopharmacol. 8 (2008) 1626
43. Lee H.S., Seo E.Y., Kang N.E., and Kim W.K. J. Nutr. Biochem. 19 (2008) 313
44. Lee S.-H., Cekanova M., and Baek S.J. Mol. Carcino. 47 (2008) 197
45. Ghayur M.N., Gilani A.H., Ahmed T., Khalid A., Nawaz S.A., Agbedahunsi J.M., Choudhary M.I., and Houghton P.J. J. Pharm. Pharmacol. 60 (2008) 1375
46. Hibino T., Yuzurihara M., Terawaki K., Kanno H., Kase Y., and Takeda A. J. Pharmacol. Sci. 108 (2008) 89
47. Nagoshi C., Shiota S., Kuroda T., Hatano T., Yoshida T., Kariyama R., and Tsuchiya T. Biol. Pharm. Bull. 29 (2006) 443
48. Non-asymmetric synthesis, see:. Fleming S.A., Dyer C.W., and Eggington J. Synth. Commun. 29 (1999) 1933
49. Kato N., Hamada Y., and Shioiri T. Chem. Pharm. Bull. 32 (1984) 1679
50. Barco A., Benetti S., Baraldi P.G., Guarneri M., Pollini G.P., and Simoni D. J. Chem. Soc., Chem. Commun. (1981) 599
51. Denniff P., Macleod I., and Whiting D.A. J. Chem. Soc., Perkin Trans.1 (1981) 82
52. Denniff P., and Whiting D.A. J. Chem. Soc., Chem. Commun. (1976) 7
53. Banno K., and Mukaiyama T. Bull. Chem. Soc. Jpn. 49 (1976) 1453
54. Hirao N., Toyama T., Takahata A., and Yasui B. Chem. Pharm. Bull. 20 (1972) 2287
55. The use of chiral precursors or kinetic resolutions, see:. Fukuda H., Tetsu M., and Kitazume T. Tetrahedron 52 (1996) 157
56. Solladie G., and Ziani-Cherif C. J. Org. Chem. 58 (1993) 2181
57. Martin M., and Guibet P. Chirality 3 (1991) 151
58. Annunziata R., Cardani S., Gennari C., and Poli G. Synthesis (1984) 702
59. Cinquini M., Cozzi F., and Gilardi A. J. Chem. Soc., Chem. Commun. 551 (1984)
60. Gall T.L., Lellouche J.-P., and Beaucourt J.-P. Tetrahedron Lett. 30 (1989) 6521
61. Baraldi P.G., Fabio M., Pollini G.P., Simoni D., Barco A., and Benetti S. J. Chem. Soc., Perkin Trans. 1 (1982) 2983
62. Enders D., Eichenauer H., and Pieter R. Chem. Ber. 112 (1979) 3703
63. Hirao N., Kawachi J., and Yasui B. Chem. Pharm. Bull. 21 (1973) 2569
64. Le Gall T., Lellouche J.P., and Beaucourt J.P. Tetrahedron Lett. 30 (1989) 6521
65. List B., Pojarliev P., and Castello C. Org. Lett. 3 (2001) 573
66. Claffey M.M., Hayes C.J., and Heathcock C.H. J. Org. Chem. 64 (1999) 8269
67. Banno K., and Mukaiyama T. Bull. Chem. Soc. Jpn. 49 (1976) 1453
68. See Supplementary data for detail.